Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|June 8, 2018
Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung AdenocarcinomaYoshiro Nakahara, Tomoya Fukui, Masayuki Shirasawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 14, 2012
[Pemetrexed as second-line treatment and beyond for elderly patients with advanced non-small-cell lung cancer]Sakiko Otani, Satoshi Igawa, Sachiyo Maki, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2006
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancerTomoko Yanaihara, Masanori Yokoba, Sayaka Onoda, et al.
Plos One|April 20, 2019
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancerMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Oncology|May 11, 2023
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase InhibitorsYuki Akazawa, Satoshi Igawa, Kaori Yamada, et al.
Oncology|February 3, 2018
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance StatusSatoshi Igawa, Masayuki Shirasawa, Tomoya Fukui, et al.
Thoracic Cancer|August 21, 2018
Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective studyHideyuki Sone, Satoshi Igawa, Masashi Kasajima, et al.
Thoracic Cancer|June 6, 2018
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance statusSatoshi Igawa, Masayuki Shirasawa, Takahiro Ozawa, et al.
Molecular and Clinical Oncology|September 3, 2019
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017Yoshiro Nakahara, Yukio Hosomi, Masahiko Shibuya, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2012
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancerMaiko Asakuma, Michiko Yamamoto, Mayuko Wada, et al.
Pageof 4